Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response

Cytokine. 1995 Aug;7(6):510-6. doi: 10.1006/cyto.1995.0069.

Abstract

Neutralizing monoclonal antibodies against the murine interleukin 1 (IL-1) type I (mAb 35F5) and type II receptor (mAb 4E2) were used to passively immunize mice prior to exogenous murine IL-1 alpha administration or a sterile-turpentine induced abscess. When mice were passively immunized with 35F5, the anorexia, weight loss and increased plasma acute phase protein levels in response to exogenous IL-1 alpha administration or a turpentine abscess were significantly attenuated. In contrast, passive immunization with 4E2 had only variable effects on food intake, body weight and the hepatic acute phase response in mice administered IL-1 alpha. In mice following a turpentine abscess, type II receptor blockade (4E2) either had no effect, or in some cases, actually increased the plasma IL-6 and acute phase protein responses. We conclude that in response to a turpentine abscess, the anorexia, weight loss and the induction of several hepatic acute phase reactants result in part from IL-1 binding to its type I receptor. Binding of IL-1 to the type II IL-1 receptor does not appear to be involved in the induction of these host nonspecific responses to inflammation.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abscess / chemically induced
  • Abscess / immunology
  • Abscess / metabolism
  • Acute-Phase Reaction / immunology
  • Acute-Phase Reaction / metabolism*
  • Animals
  • Anorexia / prevention & control
  • Antibodies, Monoclonal
  • Cells, Cultured
  • Immunization, Passive
  • Interleukin-1 / metabolism*
  • Interleukin-1 / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Receptors, Interleukin-1 / metabolism*
  • Turpentine
  • Weight Loss / drug effects

Substances

  • Antibodies, Monoclonal
  • Interleukin-1
  • Receptors, Interleukin-1
  • Turpentine